• FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • Hrv
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations

Pharmacovigilance

  • Homepage
  • Pharmacovigilance
  • New Safety Information

Croatia among the first three EU countries that introduced mobile apps for ADR reporting

18.05.2016

more

PRAC News – May 2016

17.05.2016

more

CMDh News – April 2016

09.05.2016

more

CHMP News – April 2016

02.05.2016

more

EMA completes review of inhaled corticosteroids for chronic obstructive pulmonary disease

02.05.2016

more

Start of a review on the conduct of studies at Semler Research Centre Private Ltd, Bangalore, India

02.05.2016

more

PRAC News – April 2016

19.04.2016

more

EMA reviews direct-acting antivirals for hepatitis C

19.04.2016

more

EMA reviews diabetes medicine canagliflozin

19.04.2016

more

Direct healthcare professional communication on the need to screen patients for hepatitis B virus before treatment due to risk of hepatitis B reactivation with BCR-ABL tyrosine kinase inhibitors (imatinib, dasatinib, nilotinib, bosutinib, ponatinib)

11.04.2016

more

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • »

For Patients and Public

For Health Care Professionals

For Industry Representatives

  • What is Pharmacovigilance?
  • How to Report an Adverse Drug Reaction
  • New Safety Information
    • Archive 2022
    • Archive 2021
    • Archive 2020
    • Archive 2019
    • Archive 2018
    • Archive 2017
    • Archive 2016
    • Archive 2015
    • Archive 2014
    • Archive 2013
    • Archive 2012
    • Archive 2011
    • Archive 2010
    • Archive 2009
  • Direct Healthcare Professional Communication
  • Risk minimisation measures (RMM)
  • List of serious adverse reactions
  • Information for Marketing Authorisation Holders
  • Adverse Drug Reactions Reports
  • Pandemic Influenza A/H1N1
  • Information for Marketing Authorisation Holders - Electronic Transmission of ICSRs
  • Seal for Marking of Important Safety Information
  • Pharmacovigilance and Risk Assessment Committee (PRAC) - Links
  • Medicinal Products under Additional Monitoring
  • Signal management
  • Submission of Application Documentation for Assessment of Non-Interventional Trials
  • SCOPE Project
  • Access to Databases of Suspected ADRs
  • Homepage
  • FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations
  • HALMED for:
  • Patients and Public
  • Health Care Professionals
  • Industry Representatives

Copyright © 2007-2025. Agency for Medicinal Products and Medical Devices of Croatia.
All rights reserved.